Tang Kevin bought 517 shares of Boundless Bio, Inc. at $2.40 for $1.24k on Nov 4, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
10% owner
10%
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$1,240.80Shares × reported price
Shares traded
517Common Stock
Price per share
$2.40Reported price. Read footnotes for ranges.
% of reported position traded
0.02%This security and ownership context
Holdings after
3,025,228Indirect · See Footnote
Trade date
Nov 4, 2026Buy
Filed
Nov 5, 2026, 6:14 PM ET1-day reporting delay
Accession
0001178579-26-000023Code P · Transaction 394007
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 3,024,711 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 3, 2026Buy2,255$2.40$5,412Trade 394006
Nov 5, 2026Buy8,390$2.40$20,136Trade 394008
3 transaction rows in this filing. Joint filers share the same rows.

BOLD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BOLD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +7.9%1w ago +3.7%1d ago −1.2%
Returns since7d +2.1%30d90d180d1y

Footnotes in full

F1: The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $2.38 to $2.40. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the range set forth in Footnotes 1 and 3 through 4. F2: Tang Capital Partners, LP ("TCP") beneficially owns 691,177 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 972,673 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 691,170 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 678,598 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV. F3: These shares were purchased in multiple transactions at prices ranging from $2.39 to $2.40. F4: These shares were purchased in multiple transactions at prices ranging from $2.38 to $2.40.